RegentAtlantic Capital’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$4.56M Buy
30,740
+16,041
+109% +$2.68M 0.14% 111
2022
Q2
$2.53M Buy
14,699
+985
+7% +$170K 0.08% 173
2022
Q1
$2.59M Buy
13,714
+642
+5% +$127K 0.07% 193
2021
Q4
$3.19M Buy
13,072
+1,907
+17% +$418K 0.09% 171
2021
Q3
$2.17M Buy
11,165
+53
+0.5% +$10.7K 0.07% 202
2021
Q2
$2.07M Buy
11,112
+3,835
+53% +$666K 0.06% 203
2021
Q1
$1.15M Buy
7,277
+4,321
+146% +$685K 0.04% 261
2020
Q4
$489K Sell
2,956
-2,582
-47% -$420K 0.02% 341
2020
Q3
$916K Buy
5,538
+2,780
+101% +$427K 0.04% 245
2020
Q2
$378K Buy
+2,758
New +$360K 0.02% 344
2015
Q1
Sell
-533
Closed -$22.9K 984
2014
Q4
$22.9K Buy
+533
New +$21.6K ﹤0.01% 737

Other funds holding ZTS

RegentAtlantic Capital's ZTS Position: Q3 2022 in Review

RegentAtlantic Capital increased its Zoetis (ZTS) stake by 109% in Q3 2022, buying an estimated $2.68M and bringing the position to 30,740 shares worth $4.56M. The position accounts for 0.14% of the portfolio, ranked #111.

RegentAtlantic Capital first reported a position in ZTS in Q4 2014 and has held it in 11 quarters since. 1,508 funds tracked by Wall St. Rank hold ZTS as of Q3 2022.

  • RegentAtlantic Capital held 30,740 shares of Zoetis worth $4.56M as of Q3 2022.
  • RegentAtlantic Capital bought 16,041 Zoetis shares in Q3 2022, an estimated $2.68M.
  • Zoetis made up 0.14% of RegentAtlantic Capital's portfolio in Q3 2022, its #111 holding.
  • RegentAtlantic Capital first reported a position in Zoetis in Q4 2014 and has held it in 11 quarters since.
  • 1,508 funds tracked by Wall St. Rank held Zoetis as of Q3 2022.

Based on RegentAtlantic Capital's 13F filing for Q3 2022, filed 14 Nov 2022.